SEC Stock Data Quick Answer AIM ImmunoTech Inc. reported Long-Term Debt of $1.88 million for fiscal year 2020. AIM ImmunoTech Inc. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2020 $1.88M -10.8% 2019 $2.10M -9.2% 2018 $2.32M — Quarterly Long-Term Debt Quarter Ending Long-Term Debt YoY QoQ March 31, 2021 $1.82M -11.4% -3.2% December 31, … Read more
Quick Answer AIM ImmunoTech Inc. reported Cash and Equivalents of $2.98 million for fiscal year 2025. AIM ImmunoTech Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $2.98M +75.5% 2024 $1.70M -68.7% 2023 $5.44M -79.9% 2022 $27.05M -15.7% 2021 $32.09M -16.6% 2020 $38.50M +2519.1% 2019 $1.47M +391.6% 2018 $299.0K … Read more
Quick Answer AIM ImmunoTech Inc. reported Total Assets of $5.78 million for fiscal year 2025. AIM ImmunoTech Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $5.78M -32.8% 2024 $8.61M -55.6% 2023 $19.38M -52.1% 2022 $40.49M -29.8% 2021 $57.70M -10.7% 2020 $64.58M +211.2% 2019 $20.75M +49.9% 2018 $13.85M -2.5% 2017 $14.21M … Read more
Quick Answer AIM ImmunoTech Inc. reported Diluted EPS of $8.62 per share (loss) for fiscal year 2025. AIM ImmunoTech Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$8.62 +72.1% 2024 -$30.92 -5053.3% 2023 -$0.60 -50.0% 2022 -$0.40 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, 2025 … Read more
Quick Answer AIM ImmunoTech Inc. reported Net Income of -$13.96 million for fiscal year 2025. AIM ImmunoTech Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$13.96M +19.4% 2024 -$17.32M +40.2% 2023 -$28.96M -48.9% 2022 -$19.45M -1.7% 2021 -$19.13M -32.8% 2020 -$14.40M -53.1% 2019 -$9.40M +4.3% 2018 -$9.83M -19.0% 2017 -$8.26M … Read more
Quick Answer AIM ImmunoTech Inc. reported Revenue (ASC 606) of $88.0 thousand for fiscal year 2025. AIM ImmunoTech Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $88.0K -48.2% 2024 $170.0K -15.8% 2023 $202.0K +43.3% 2022 $141.0K +4.4% 2021 $135.0K -17.2% 2020 $163.0K +16.4% 2019 $140.0K -61.9% 2018 $367.0K … Read more
Quick Answer AIM ImmunoTech Inc. reported Total Revenue of $88.0 thousand for fiscal year 2025. AIM ImmunoTech Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $88.0K -48.2% 2024 $170.0K -15.8% 2023 $202.0K +43.3% 2022 $141.0K +4.4% 2021 $135.0K -17.2% 2020 $163.0K +16.4% 2019 $140.0K -61.9% 2018 $367.0K -16.0% 2017 $437.0K … Read more
Quick Answer AIM ImmunoTech Inc. reported Total Revenue of $88.0 thousand for fiscal year 2025. AIM ImmunoTech Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $88.0K-48.2% $170.0K-15.8% $202.0K+43.3% $141.0K+4.4% $135.0K-17.2% $163.0K+16.4% Revenue (ASC 606) $88.0K-48.2% $170.0K-15.8% $202.0K+43.3% $141.0K+4.4% $135.0K-17.2% $163.0K+16.4% Net Income -$13.96M+19.4% -$17.32M+40.2% -$28.96M-48.9% -$19.45M-1.7% -$19.13M-32.8% -$14.40M-53.1% … Read more
Quick Answer Jianpu Technology Inc. reported Shares Outstanding of 372.47 million shares for fiscal year 2024. Jianpu Technology Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 372.47M -12.3% 2023 424.78M +0.1% 2022 424.45M +0.2% 2021 423.68M +0.0% 2020 423.63M +0.2% 2019 422.68M +1.8% 2018 415.25M +0.2% 2017 414.29M +19.9% 2017 … Read more
Quick Answer Jianpu Technology Inc. reported Gross Profit of $71.66 million for fiscal year 2020. Jianpu Technology Inc. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2020 $71.66M -94.5% 2019 $1.30B -24.6% 2018 $1.73B +32.7% 2017 $1.30B — Jianpu Technology Inc. showed a decrease of -94.5% in Gross Profit compared to the … Read more